| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.29 | 0.05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |